Anti-tubercular Activity of Ruthenium (II) Complexes with Polypyridines

References

• B Heym, and ST Cole. (1997). Multidrug resistance in Mycobacterium tuberculosis. Int J Antimicrob Agents 8:61–70.
   PubMed Web of Science ®Google Scholar
• LA Basso, and JS Blanchard. (1998). Resistance to antitubercular drugs. Adv Exp Med Biol 456:115–144.
   PubMedGoogle Scholar
• A Telenti, and M Iseman. (2000). Drug-resistant tuberculosis: What do we do now?. Drugs 59:171–179.
   PubMed Web of Science ®Google Scholar
• C Loiez-Durocher, A Vachee, and N Lemaitre. (2000). Drug resistance in Mycobacterium tubercolosis: Diagnostic methods. Ann Biol Clin 58:291–297.
   PubMedGoogle Scholar
• K Duncan. (1997). Prospects for new anti-tuberculosis drugs. J Pharm Pharmacol 49:21–23.
   Google Scholar
• K Duncan. (1997). Tuberculosis: Annual update. Expert Opin Ther Pat 7:129–137.
   Web of Science ®Google Scholar
• C Grassi. (1997). New drugs for tuberculosis. Expert Opin Invest Drugs 6:1211–1226.
   PubMedGoogle Scholar
• CE Barry. (1997). New horizons in the treatment of tuberculosis. Biochem Pharmacol 54:1165–1172.
   PubMed Web of Science ®Google Scholar
• K. Tuberculosis Duncan. (1998). Expert Opin Ther Pat 8:137–142.
   Web of Science ®Google Scholar
• NJC Snell. (1998). The treatment of tuberculosis: Current status and future prospects. Expert Opin Invest Drugs 7:545–552.
   PubMedGoogle Scholar
• DC Crick, and PJ Brennan. (2000). Antituberculosis drug research. Curr Opin Anti-Infect Invest Drugs 2:154–163.
   Google Scholar
• A Andreani, M Granaiola, A Leoni, A Locatelli, R Morigi, and M Rambaldi. (2001). Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles. Eur J Med Chem 36:743–746.
   PubMed Web of Science ®Google Scholar
• B Bottari, R Maccari, F Monforte, R Ottanaa, E Rotondo, and MG Vigorita. (2000). Antimycobacterial in vitro activity of cobalt (II) isonicotinoylhydrazone complexes. Part 10. Bioorg Med Chem Lett 10:657.
   PubMed Web of Science ®Google Scholar
• A Kumar, and D Kumar. (2007). Synthesis and antimicrobial activity of metal complexes from 2-(1′/2′-hydroxynaphthyl)benzoxazoles. ARKIVOC (XIV):117–125.
   Google Scholar
• B Bottari, R Maccari, F Monforte, R Ottana, MG Vigorita, G Bruno, F Nicolo, A Rotondo, and E Rotondo. (2001). Nickel (II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI. Bioorg Med Chem 9:2203–2211.
   PubMed Web of Science ®Google Scholar
• L Messori, P Orioli, D Vullo, E Alessio, and E Iengo. (2000). A spectroscopic study of the reaction of NAMI, a novel ruthenium (III) anti-neoplastic complex, with bovine serum albumin. Eur J Biochem 267:1206–1213.
   PubMedGoogle Scholar
• FP Dwyer, IK Reid, A Shulman, GM Laycock, and S Dixon. (1969). Biological actions of 1,10-phenanthroline and 2,2′-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds. 1. Bacteriostatic action on selected gram-positive, Gram-negative and acid-fast bacteria. Austral J Exp Bio Med Sci 47:203–218.
   PubMedGoogle Scholar
• N Sam, S Elkadiri, H Le Bozec, L Toupet, M Daoudi, N Bitit, T Ben Hadda, and PH Dixneuf. (1996). Novel trichloroindolizine derivatives via intramolecular acylation of a bis(chloroacyl)bipyridine. J Chem Soc Perkin Trans 15 (9):1571–1573. (b) Ben Hadda T, Sam N, Le Bozec H, Dixneuf PH. Carbonyl and chloro complexes of ruthenium (II) containing 3,3′-diester-2,2′-bipyridyl ligands, Inorg Chem Comm, 1999, 2, 460–462. (c) Ben Hadda T, Zidane I, Moya SA, LeBozec H. Soluble containing ruthenium carbonyl complexes new sterically hindered bipyridine ligands Polyhedron
   Google Scholar
• L Collins, and SG Franzblau. (1997). Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41:1004–1009.
   PubMed Web of Science ®Google Scholar
• JK Hurst. (2005). Water oxidation catalyzed by dimeric μ-oxo bridged ruthenium diimine complexes. Coord Chem Rev 249:313–328. (b) Chatterjee D, Mitra A, Shepherd RE. Oxo-transfer catalysis from t-BuOOH with C–H bond insertion using tridentate Schiff-base-chelate complexes of ruthenium(III). Inorg Chim Acta, 357 (2004), 980–990. (c) Chanda N, Mondal, B, Puranik, VG, Lahiri GK. Ruthenium monoterpyridine complexes incorporating α,α′-diimine based ancillary functions. Synthesis, crystal structure, spectroelectrochemical properties and catalytic aspect. Polyhedron 2002;21:2033–2043. (d) Chatterjee D, Mitra A, Mukherjee S. Oxidation of benzene with tert-butylhydroperoxide catalyzed by a novel [RuIII(amp)(bipy)(H2O)]+ complex: First report of homogeneously catalyzed oxo-transfer reaction in benzene oxidation. J Mol Cata A Chem 2001;165: 295–298. (e) Chatterjee D, Mitra A. Oxidation of organic substrates catalyzed by a novel mixed-ligand [RuIII(app)(pic)(H2O)]+ complex Inorg Chem Comm, 2000;3:640–644
   Web of Science ®Google Scholar
• F Frézard, C Demicheli, C Ferreira, and MAP Costa. (2001). Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate. Antimicrob Agents Chemother 913–916.
   PubMedGoogle Scholar
• D Chatterjee, and A Mitra. (2006). Ruthenium polyaminocarboxylate complexes. Platinum Metals Rev 50 (1):2–12.
   Google Scholar
• ZH Chohan, M Arif, MA Akhtar, and CT Supuran. (2006). Metal-based antibacterial and antifungal agents: Synthesis, characterization, and in vitro biological evaluation of Co(II), Cu(II), Ni(II), and Zn(II) complexes with amino acid-derived compounds. Bioinorg Chem Appl 1–13.
   Google Scholar
• ZH Chohan, and HA Shad. (2008). Structural elucidation and biological significance of 2-hydroxy-1-naphthaldehyde derived sulfonamides and their first row d-transition metal chelates. J Enz Inhib Med Chem (in press)
   Google Scholar
• ZH Chohan, CT Supuranm, and A Scozzafava. (2005). Metal binding and antibacterial activity of ciprofloxacin complexes. J Enz Inhib Med Chem 20 (3):303–307.
   PubMedGoogle Scholar
• ZH Chohan, and CT Supuranm. (2006). Metalloantibiotics: Synthesis, characterization and in-vitro antibacterial studies on cobalt (II), copper (II), nickel (II) and zinc (II) complexes with cloxacillin. J Enz Inhib Med Chem 21 (4):441–448.
   PubMedGoogle Scholar